top of page
About:
The Rainier study is being conducted to evaluate a monthly study drug versus placebo in people with immunoglobulin A
nephropathy (IgAN) to learn if it might help their symptoms and how it impacts the disease.
Eligibility
-
​Are 18 years or older
-
Diagnosed with IgAN from a kidney biopsy within the last 10 years
-
Receiving stable doses of standard IgAN treatments (if prescribed)​
​
**There are other criteria that potential participants must meet in order to qualify for the study**
If you’re interested in participating in one of our Research Studies:
Call
303-232-3366
ext 2150, 2170 or 2190
bottom of page